Chemoinformaics analysis of 14-hydroxy-heneicosanoic acid
| Molecular Weight | 342.564 | nRot | 19 |
| Heavy Atom Molecular Weight | 300.228 | nRig | 1 |
| Exact Molecular Weight | 342.313 | nRing | 0 |
| Solubility: LogS | -4.677 | nHRing | 0 |
| Solubility: LogP | 7.126 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 65.4813 |
| nHD | 2 | BPOL | 43.0027 |
| QED | 0.264 |
| Synth | 2.469 |
| Natural Product Likeliness | 0.679 |
| NR-PPAR-gamma | 0.985 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.01 |
| HIA | 0.014 |
| CACO-2 | -5.161 |
| MDCK | 0.0000295 |
| BBB | 0.018 |
| PPB | 0.9884 |
| VDSS | 0.748 |
| FU | 0.0096138 |
| CYP1A2-inh | 0.202 |
| CYP1A2-sub | 0.187 |
| CYP2c19-inh | 0.151 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.118 |
| CYP2c9-sub | 0.99 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.041 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.011 |
| CL | 3.58 |
| T12 | 0.551 |
| hERG | 0.086 |
| Ames | 0.004 |
| ROA | 0.005 |
| SkinSen | 0.94 |
| Carcinogencity | 0.04 |
| EI | 0.955 |
| Respiratory | 0.734 |
| NR-Aromatase | 0.145 |
| Antiviral | No |
| Prediction | 0.614389 |